IL4 and myeloproliferative disorder: The explanation for this phenomenon is based on a recently published article by Melo-Cardenas et al, in which the authors show that progression of myeloproliferative disorders is associated with increased IL-13 levels, whereas reductions in IL-4 and IL-13 are associated with reduced features of these disorders (19).